Aside from its weight loss benefits, semaglutide lowers the risk of many chronic diseases linked to obesity, including high blood pressure, heart disease, diabetes, and stroke.
Therefore, we aimed to do a systematic review and meta-analysis of randomised controlled trials to evaluate the association between dipeptidyl peptidase-4 inhibitors and gallbladder or biliary diseases in patients with type 2 diabetes
Annual membership fee: $199 per year (or $16.59/month) $99 per year (or $8.25/month) for Prime members The membership gives you access to 24/7 on-demand virtual care, messaging with your care team, and same- or next-day in-person appointments
Fatigue that improves with fluids, protein, steadier meals, and better sleep may be related to adjustment
Sign up for exclusive offers, original stories, events and more
Davies et al, 2018